DRUG · Mapped RxNorm record
Doxorubicin
Normalized identity: doxorubicinView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Neoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast Cancer
NCT00256243
Drugs and interventions used in this trial
6 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Cyclophosphamide
Normalized identity: cyclophosphamideView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Paclitaxel
Normalized identity: paclitaxelView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Carboplatin
Normalized identity: carboplatinView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
GM-CSF
Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
Trastuzumab
Normalized identity: trastuzumabView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedNeoadjuvant Biweekly Treatment Followed by Weekly Treatment of Breast Cancer
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Interventions
DoxorubicinDRUG · verified · RxNorm: doxorubicin
CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
PaclitaxelDRUG · verified · RxNorm: paclitaxel
CarboplatinDRUG · verified · RxNorm: carboplatin
GM-CSFDRUG
TrastuzumabDRUG · verified · RxNorm: trastuzumab
Sponsors & collaborators
Rita Sanghvi, Mehtalead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00256243 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.